Syndax Pharmaceuticals Inc (SNDX)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Syndax Pharmaceuticals Inc’s filings yet. We add companies and filings all the time.
Track SNDX and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $197.18M |
| GOLDMAN SACHS GROUP INC | Aug 14, 2026 | $128.13M |
| STATE STREET CORPORATION | Sep 22, 2026 | $123.69M |
| BANK OF AMERICA CORP /DE/ | Aug 14, 2026 | $88.43M |
| Vanguard Capital Management | Aug 13, 2026 | $85.86M |
SNDX's filings are public. The insight is one click away.
Scrutar's AI reads every SNDX filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a SNDX filing.
Get an email when SNDX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.